Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tiotropium Respimat add-on therapy in children with severe persistent asthma
2011-001777-43Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tiotropium in severe asthma (3 arms), sponsored by Boehringer Ingelheim. Primary endpoint: Peak forced expiratory volume in one second response within 3 hours post dosing. Started Mar 2012; status: completed.
02
Drugs
tiotropium
03
Conditions
severe asthma
Beyond the preview
Go deeper on 2011-001777-43.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-001777-43.